Activating c-KIT mutations have been implicated in a variety of cancers [30] starting with GIST (Gastrointestinal stromal tumors) and CML (Chronic Myelogenous Leukemia). Here, KIT is linked to chronic myelogenous leukemia, BCR-ABL1 positive.